Clinical Trials Research
LA JOLLA PHARMACEUTICAL COMPANY REPORTS FOURTH QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS
Published in Healthcare Mergers, Acquisitions and Ventures Week, March 24th, 2007
La Jolla Pharmaceutical Company (Nasdaq: LJPC) reported a net loss for the fourth quarter ended December 31, 2006 of $10.7 million, or $0.33 per share (on 32.7 million weighted average shares), compared to a net loss of $6.0 million, or $0.33 per share (on 18.3 million weighted average shares), for the fourth quarter of 2005. The net loss for the twelve months ended December 31, 2006 was $39.4 million, or $1.21 per share (on 32.6 million weighted average shares), compared to a net loss of $27.4 million, or $1.77 per share (on 15.4 million weighted average shares), for the same period in 2005.
Research and development expenses increased to $9.2 million for the three...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- Abdominal Aortic Aneurysm
Abdominal Aortic Aneurysm Stent Graft Market to Grow to $550 Million by 2011 - Acne Vulgaris
CollaGenex Pharmaceuticals Announces Positive Results of Phase 2 Dose-Finding Study of Incyclinide for the Treatment of Acne - Acromegaly Therapy
Research from Pfizer Pharma GmbH has provided new data on acromegaly therapy - Acusphere
Acusphere Announces Key Promotions in Research and Development - Adaptis
Adaptis to Offer Subrogation Services Through SOCRATES INC. - ADVENTRX Pharmaceuticals, Inc.
ADVENTRX Announces M. Ross Johnson to Retire as Board Chairman - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
